clinical development CNS
Update on Regulations Surrounding CNS in Europe: BfArM session on Optimising Clinical Development for CNS
January 11 by Pharma IQ NewsDr. Karl Broich, Vice President, BfArM, will discuss the new regulatory landscape as well as projected amendments to the current guidance documents on CNS clinical trials at Optimising Clinical...
Market for CNS Biomarkers Predicted to Grow to $3.2 Billion by 2015
December 02 by Pharma IQBiomarkers are now being used by a large number of companies in the biopharmaceutical industry - and one of the key therapeutic areas where they are utilised is in CNS drug development, wher...
